Cellectar Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.60

+0.12 (+4.84%)

As of Aug 14, 10:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,487.7% upside

Low Target $32.58

Average Target $41.28

High Target $58.47

Current Price $2.60

Current
$2.60

Target
$41.28

$32.58 $41.28 avg $58.47

Scenario Analysis

Bear Case

$32.58

1,153.1%

Low target

Base Case

$41.28

+1,487.7%

Avg target

Bull Case

$58.47

+2,148.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.52

-60.1% from high

52-Week Low

$2.20

+18.2% from low

Target vs 52W High

$41.28

+533.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%